Literature DB >> 11160180

Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo.

C Kurts1, M Cannarile, I Klebba, T Brocker.   

Abstract

The mechanism of cross-presentation enables professional APCs to induce CD8 T cell-mediated immune responses against exogenous Ags. Through this mechanism, APCs can induce either immunity against infectious pathogens or tolerance against self-Ag residing in extralymphatic locations. An unanswered question in this field concerns the identity of the cross-presenting APC. All major classes of professional APCs, particularly dendritic cells, macrophages, and B cells, have previously been shown to be able to cross-present Ags in vitro. In the present study, we have created transgenic mice where MHC class I expression is driven selectively in dendritic cells and provide direct in vivo evidence that dendritic cells are sufficient to cross-present exogenous self-Ags and induce Ag-specific cell division of CD8-positive T cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160180     DOI: 10.4049/jimmunol.166.3.1439

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens.

Authors:  Steffen Jung; Derya Unutmaz; Phillip Wong; Gen-Ichiro Sano; Kenia De los Santos; Tim Sparwasser; Shengji Wu; Sri Vuthoori; Kyung Ko; Fidel Zavala; Eric G Pamer; Dan R Littman; Richard A Lang
Journal:  Immunity       Date:  2002-08       Impact factor: 31.745

Review 2.  Cross-presentation: dendritic cells and macrophages bite off more than they can chew!

Authors:  Sven Brode; Paul A Macary
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

Review 3.  Cross-priming in health and disease.

Authors:  Christian Kurts; Bruce W S Robinson; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

Review 4.  Pathways for antigen cross presentation.

Authors:  Pierre Guermonprez; Sebastian Amigorena
Journal:  Springer Semin Immunopathol       Date:  2004-12-03

5.  Abortive activation precedes functional deletion of CD8+ T cells following encounter with self-antigens expressed by resting B cells in vivo.

Authors:  Joanne M Fraser; Claire N Janicki; Ben J E Raveney; David J Morgan
Journal:  Immunology       Date:  2006-06-23       Impact factor: 7.397

6.  Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization.

Authors:  Yukai He; Jiying Zhang; Cara Donahue; Louis D Falo
Journal:  Immunity       Date:  2006-05       Impact factor: 31.745

7.  CD8+ regulatory T cells generated by neonatal recognition of peripheral self-antigen.

Authors:  Roland Reibke; Natalio Garbi; Ruth Ganss; Günter J Hämmerling; Bernd Arnold; Thilo Oelert
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-28       Impact factor: 11.205

8.  Dendritic cells program non-immunogenic prostate-specific T cell responses beginning at early stages of prostate tumorigenesis.

Authors:  Marianne A Mihalyo; Adam T Hagymasi; Aaron M Slaiby; Erin E Nevius; Adam J Adler
Journal:  Prostate       Date:  2007-04-01       Impact factor: 4.104

9.  Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice.

Authors:  James de Jersey; Sarah L Snelgrove; Stephanie E Palmer; Simon A Teteris; Arno Mullbacher; Jacques F A P Miller; Robyn M Slattery
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-17       Impact factor: 11.205

10.  Comparative therapeutic effects of orally administered 1,25-dihydroxyvitamin D(3) and 1alpha-hydroxyvitamin D(3) on type-1 diabetes in non-obese diabetic mice fed a normal-calcaemic diet.

Authors:  J P Driver; O Foreman; C Mathieu; E van Etten; D V Serreze
Journal:  Clin Exp Immunol       Date:  2007-11-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.